2008 Federal Circuit
|
|
- Kristian Charles
- 6 years ago
- Views:
Transcription
1 2008 Federal Circuit AIPLA IP Practice in Japan Committee Pre-Meeting Ranga Sourirajan January 27, 2009 The opinions expressed herein are not to be attributed to the Firm s clients En Banc Opinions In re Bilski Egyptian Goddess v. Swisa 1
2 Panel Opinions and Order Declaratory Judgment Personal jurisdiction (Avocent Huntsville) Subject matter jurisdiction (Caraco; Cat Tech; Janssen; Micron; Prasco) Jurisdiction In Personam Jurisdiction (Campbell Pet; Medical Solutions) Subject Matter Jurisdiction (Excelstor Tech.) Standing (Lucent; Mars) Writ of Mandamus (In re TS Tech) Multidistrict Litigation (In re Omeprazole Pat. Litig.) Settlement Agreement and Antitrust (In re Ciprofloxacin Hydrochloride) Open Source License (Jacobsen) Standards Setting (Qualcomm) ITC s Exclusion Order (Kyocera Wireless) Panel Opinions and Order Claim Construction (800 Adept) Means-Plus-Function (Welker Bearing; Net Moneyin) Reverse Doctrine of Equivalents (Roche) Invalidity Indefinite (Star Scientific) Obviousness (In re DBC; Asyst Tech.) Lack of Written Description (In re Alonso; Carnegie Mellon Univ.) Anticipation (Cohesive Techs.) Obviousness-Type Double Patenting (In re Basell Poliolefine) Inequitable Conduct (Star Scientific) Joint Infringement (Muniauction) Damages Subsidiary (Mars) Exceptional Case (Takeda Chemical; Nilssen) 2
3 Panel Opinions and Order Preliminary Injunction Procedural (Proctor & Gamble) Substantive (Abbott Labs.) Reexamination (In re Swanson; Cooper Techs.) Maintenance Fee (Burandt) Declaratory Judgment Act The judicial Power shall extend to all Cases... to Controversies... U.S. Const. art. III, 2 3
4 MedImmune v. Genentech MedImmune manufactures Synagis, a drug to treat respiratory tract disease Genentech granted MedImmune a license to make, use and sell subject matter covered by a patent and a pending application After pending application issued as patent, Genentech sent a letter to MedImmune alleging that Synagis infringed its patent and demanded royalty MedImmune believed patent to be invalid and unenforceable, and the letter a clear threat to enforce patent; MedImmune filed DJ action C.D. Cal. dismissed the DJ action for lack of subject matter jurisdiction under the reasonable apprehension test Fed. Cir. affirmed the DCT decision; MedImmune filed cert A justiciable declaratory judgment action exists when the facts alleged, under all the circumstances, show that there is a substantial controversy, between parties having adverse legal interests, of sufficient immediacy and reality to warrant the issuance of a declaratory judgment Avocent Huntsville v. Aten Int l Avocent Huntsville and Avocent Redmond (Avocent), and Aten, a Taiwanese Co., compete in keyboard-video-mouse switches market Aten owns U.S. Pat. Nos. 6,957,287 and 7,035,112 re: KVM switches Aten sent a letter to Avocent Corp. (parent), a letter to Amazon.com; a letter to Avocent Redmond during ongoing litigation in W.D. Wash. Avocent filed DJ in N.D. Ala. DCT grants Aten s FRCP 12(b)(2) MTD for lack of personal jurisdiction No systematic and continuous contact by Aten with Alabama Arguments Avocent: general jurisdiction under stream of commerce theory Aten: no specific jurisdiction based on letters asserting infringement (1) Mere acts of making, using, offering to sell, selling, or importing products to a forum do not satisfy the other activities requirement for specific personal jurisdiction over patentee; (2) no specific jurisdiction over patentee based only on letters asserting infringement 4
5 Avocent Huntsville v. Aten Int l Reasoning General jurisdiction: Def. have continuous and systematic contacts with forum Specific jurisdiction: (1) Def. purposefully directed activities at forum (2) claim arises out of or relates to the activities (3) jurisdiction assertion is reasonable and fair Letters threatening suit by themselves are insufficient to create personal jurisdiction because it would not comport with fair play and substantial justice other activities in addition to cease and desist letters to meet relate to requirement: judicial or extra-judicial patent enforcement within forum; entering into exclusive license agreement imposing obligations on forum resident Dissent (Newman, J.) Personal jurisdiction exists because (1) infringement letter sent to Avocent Corp. s President in Ala.; (2) sale of Aten s products through distributors and retail stores in Ala.; (3) Aten s contacts with Avocent s customers; (4) Avocent s manufacture of accused infringing products; (5) no clear alternative forum; (6) due process and fairness Janssen Pharmaceutica v. Apotex Janssen holds NDA for Risperdal Oral Solution, drug to treat schizophrenia Janssen owns U.S. Pat. Nos. 4,804,663, 5,453,425, and 5,616,587 Apotex stipulated to infringement, validity and enforceability of 663 patent Teva first ANDA applicant on 425 and 587 patents; Apotex second filed ANDA on 425 and 587 patents and later amended to add 663 patent Janssen sued Apotex for infringement of 663 patent Apotex counterclaimed DJ of noninfringement of 425 and 587 patents Janssen gave Apotex a covenant-not-to-sue with respect to 425 and 587 patents D. N.J. dismisses Apotex s DJ action for noninfringement against Janssen 5
6 Janssen Pharmaceutica v. Apotex (1) second ANDA applicant s exclusion from the market because of first ANDA applicant s entitlement to statutory exclusionary period; (2) possible delay in the future of a first ANDA applicant s launch of generic product; or (3) covenant-not-to-sue which protects ANDA applicant s affiliates, suppliers and downstream customers do not give rise to actual controversy Reasoning If Apotex had not stipulated to validity of 663 patent, Caraco would be controlling At the time when DCT entered final judgment, Apotex s harm was speculative having manufactured language of covenant-not-to-sue expressly covers suppliers and affiliates Prasco v. Medicis Pharm. Prasco makes generic benzoyl peroxide cleansing product Prasco brought DJ of noninfringement; at the time, Prasco had not marketed its product and defendants did not know of its existence Defendants filed MTD; later, Prasco sent a sample and requested covenant-notto-sue, which defs. declined; Prasco filed amended complaint DCT granted MTD finding no case or controversy under the reasonable apprehension test DCT noted that result would be the same since there was no definite and concrete dispute that touches legal relations of parties Patentee s marking of its products, prior suit involving other patents, and patentee s refusal to sign covenant-not-to-sue do not create immediate and real controversy Reasoning No jurisdiction without patentee s affirmative act; mere knowledge of patent or perceived risk of infringement insufficient Laundry list: creates reasonable apprehension of suit, demands royalty, creates barrier to regulatory approval 6
7 Cat Tech v. TubeMaster Cat Tech owns U.S. Pat. No. 6,905,660 directed to method for using loading devices to place catalyst particles into multi-tube chemical reactors TubeMaster designs 4 different configurations of loading devices used to put catalyst into reactor tubes Cat Tech sued TubeMaster for infringement; TubeMaster counterclaimed for declaration of noninfringement; Cat Tech amended complaint seeking DJ of infringement DCT grants TubeMaster s motion for declaration of noninfringement because a live controversy existed as to certain design configurations Cat Tech v. TubeMaster DCT may issue a declaratory judgment when the declaratory judgment plaintiff has taken significant, concrete steps to conduct infringing activity and the dispute meets the immediacy and reality requirements Reasoning Meaningful preparation to conduct infringing activity an important element in totality of circumstances immediacy and reality requirements must be met for justiciability immediacy requirement is satisfied because TubeMaster can expeditiously solicit and fill orders for loading devices reality requirement is satisfied because TubeMaster s technology is substantially fixed 7
8 Caraco Pharm. Labs. v. Forest Labs. Forest holds NDA for Lexapro, used to treat depression; U.S. Pat. No. Re. 34, 712 covers pure forms of escitalopram, U.S. Pat. No. 6,916,941 covers crystalline particles of escitalopram oxate Ivax Pharm. filed ANDA application for 712 and 941 patents; Forest sued Ivax for infringement of 712 patent and won Caraco later filed ANDA for both patents; Forest sued for infringement of 712 patent; Caraco filed DJ of noninfringement of 941 patent; Forest unilaterally granted an irrevocable covenant-not-to-sue for 941 patent infringement E.D. Mich. dismissed Caraco s DJ action because covenant-not-to-sue eliminates controversy between parties In the context of Hatch-Waxman framework, Art. III controversy exists even when the patentee grants a covenant-not-to-sue because patentee s actions effectively prevent FDA from approving ANDA Caraco Pharm. Labs. v. Forest Labs. Reasoning Action is justiciable only if (1) plaintiff has standing; (2) issues are ripe; and (3) case is not moot Caraco satisfies standing requirements because (1) restraint on free exploitation of non-infringing goods is injury-in-fact; (2) injury is traceable to patentee due to listing of patents in the Orange-book; and (3) injury-in-fact is redressible by a favorable judgment Issue is ripe because (1) Caraco submitted its generic drug product for FDA approval; and (2) withholding court consideration would have immediate and substantial impact on Caraco Covenant-not-to-sue does not render action moot because Caraco can trigger exclusivity period only by court judgment Dissent (Friedman, J.) First ANDA filers may delay other generic drug manufacturers is speculative Congress may amend the statute so as not to defeat the purpose of legislation 8
9 Micron Tech. v. Mosaid Techs. Mosaid owns several DRAM patents; Mosaid sent warning letter and follow-up letters to DRAM manufacturers (Samsung, Hynix, Infineon, Micron) Mosaid sued Samsung, Hynix, and Infineon; later settled Micron filed DJ in N.D. Cal. of noninfringement of 14 Mosaid patents; next day, Mosaid filed infringement action in E.D. Tex. N.D. Cal. grants Mosaid s MTD finding lack of subject matter jurisdiction under reasonable apprehension of suit test Alternatively, N.D. Cal. held that it would exercise discretion and decline to hear the case because Micron s DJ action is tenuous at best and E.D. Tex. action is broader Micron Tech. v. Mosaid Techs. Issuance of declaratory judgment is warranted when all the circumstances (threatening letters, behavioral observations, public statements and annual reports) show a substantial controversy between parties of adverse legal interests of sufficient immediacy and reality. In cases with competing forum interests, convenience factors must be considered Reasoning Four-year elapse period between last letter and suit unavailing due to negotiations with other DRAM manufacturers Recent public statements and annual reports confirm intent to pursue aggressive litigation strategy Objectives of Declaratory Judgment Act would be met if case is heard by N.D. Cal. than by forum of later-filed suit 9
10 Post-MedImmune DJ Actions - Summary Adenta GmbH v. OrthoArm, Inc., 501 F.3d 1364 (Fed. Cir. 2007) (Fed. Cir. affirms grant of DJ) Avocent Huntsville Corp. v. Aten Int l Co., Ltd., 2008 U.S. App. LEXIS (Fed. Cir. Dec. 16, 2008) (Fed. Cir. affirms dismissal for lack of personal jurisdiction) Benitec Austl., Ltd. v. Nucleonics, Inc., 495 F.3d 1340 (Fed. Cir. 2007) (Fed. Cir. affirms dismissal of DJ action) Cat Tech LLC v. TubeMaster, Inc., 528 F.3d 871 (Fed. Cir. 2008) (Fed. Cir. affirms grant of DJ) Caraco Pharm. Labs., Ltd. v. Forest Labs., Ltd., 527 F.3d 1278 (Fed. Cir. 2008) (Fed. Cir. reverses dismissal of DJ action) Janssen Pharmaceutica, N.V. v. Apotex, Inc., 540 F.3d 1353 (Fed. Cir. 2008) (Fed. Cir. affirms dismissal of DJ action) Micron Tech., Inc. v. Mosaid Techs. Inc., 518 F.3d 897 (Fed. Cir. 2008) (Fed. Cir. reverses dismissal of DJ action) Prasco, LLC v. Medicis Pharm. Corp., 537 F.3d 1329 (Fed. Cir. 2008) (Fed. Cir. affirms dismissal of DJ action) SanDisk Corp. v. STMicroelectonics, Inc., 480 F.3d 1372, 1380 (Fed. Cir. 2007) (Fed. Cir. vacates dismissal of DJ action) Sony Elecs., Inc. v. Guardian Media Techs., Ltd., 497 F.3d 1271 (Fed. Cir. 2007) (Fed. Cir. reverses dismissal of action for lack of subject matter jurisdiction) Teva Pharms. USA, Inc. v. Novartis Pharms. Corp., 482 F.3d 1330 (Fed. Cir. 2007) (Fed. Cir. reverses dismissal of DJ action) Final Thoughts on DJ Actions Promise not to sue Covenant-not-to-sue Stipulation of validity Unilateral grant Infringement analysis Royalty demands Barriers to regulatory approval Effect of public statements and annual reports Elapse period 10
11 List of Cases MedImmune Inc. v. Genentech Inc., 127 S. Ct. 764 (2007) 800 Adept, Inc. v. Murex Sec., Ltd., 539 F.3d 1354 (Fed. Cir. 2008) Abbott Labs. v. Sandoz, Inc., 544 F.3d 1341 (Fed. Cir. 2008) Asyst Techs., Inc. v. Emtrak, Inc., 544 F.3d 1310 (Fed. Cir. 2008) Avocent Huntsville Corp. v. Aten Int l Co., Ltd., 2008 U.S. App. LEXIS (Fed. Cir. Dec. 16, 2008) Burandt v. Dudas, 528 F.3d 1329 (Fed. Cir. 2008) Campbell Pet Co. v. Miale, 542 F.3d 879 (Fed. Cir. 2008) Carnegie Mellon Univ. v. Hoffmann La Roche Inc., 541 F.3d 1115 (Fed. Cir. 2008) Caraco Pharm. Labs., Ltd. v. Forest Labs., Ltd., 527 F.3d 1278 (Fed. Cir. 2008) Cat Tech LLC v. TubeMaster, Inc., 528 F.3d 871 (Fed. Cir. 2008) Cohesive Techs., Inc. v. Waters Corp., 543 F.3d 1351 (Fed. Cir. 2008) Cooper Techs. Co. v. Dudas, 536 F.3d 1330 (Fed. Cir. 2008) Egyptian Goddess v. Swisa Inc., 543 F.3d 665 (Fed. Cir. 2008) (en banc) Excelstor Tech., Inc. v. Papst Licensing GmbH & Co. KG, 541 F.3d 1373 (Fed. Cir. 2008) In re Alonso, 2008 U.S. App. LEXIS (Fed. Cir. Oct. 30, 2008) In re Basell Poliolefine Italia S.P.A., 547 F.3d 1371 (Fed. Cir. 2008) In re Bilski, 545 F.3d 943 (Fed. Cir. 2008) (en banc) List of Cases In re Ciprofloxacin Hydrochloride Antitrust Litig., 544 F.3d 1323 (Fed. Cir. 2008) In re DBC, 545 F.3d 1373 (Fed. Cir. 2008) In re Omeprazole Pat. Litig. v. Apotex Corp., 536 F.3d 1361 (Fed. Cir. 2008) In re Swanson, 540 F.3d 1368 (Fed. Cir. 2008) In re TS Tech USA, 2008 U.S. App. LEXIS (Fed. Cir. Dec. 29, 2008) Jacobsen v. Katzer, 535 F.3d 1373 (Fed. Cir. 2008) Janssen Pharmaceutica, N.V. v. Apotex, Inc., 540 F.3d 1353 (Fed. Cir. 2008) Kyocera Wireless Corp. v. ITC, 545 F.3d 1340 (Fed. Cir. 2008) Lucent Techs., Inc. v. Gateway, Inc., 543 F.3d 710 (Fed. Cir. 2008) Mars, Inc. v. Coin Acceptors, Inc., 527 F.3d 1359 (Fed. Cir. 2008) Med. Solutions, Inc. v. C Change Surgical LLC, 541 F.3d 1136 (Fed. Cir. 2008) Micron Tech., Inc. v. Mosaid Techs. Inc., 518 F.3d 897 (Fed. Cir. 2008) Muniauction, Inc. v. Thomson Corp., 532 F.3d 1318 (Fed. Cir. 2008) Net Moneyin, Inc. v. Verisign, Inc., 545 F.3d 1359 (Fed. Cir. 2008) Nilssen v. Osram Sylvania, Inc., 528 F.3d 1352 (Fed. Cir. 2008) Prasco, LLC v. Medicis Pharm. Corp., 537 F.3d 1329 (Fed. Cir. 2008) Proctor & Gamble Co. v. Kraft Foods Global, Inc., 549 F.3d 842 (Fed. Cir. 2008) Qualcomm Inc. v. Broadcom Corp., 548 F.3d 1004 (Fed. Cir. 2008) 11
12 List of Cases Roche Palo Alto LLC v. Apotex, Inc., 531 F.3d 1372 (Fed. Cir. 2008) Star Scientific, Inc. v. R.J. Reynolds Tobacco Co., 537 F.3d 1357 (Fed. Cir. 2008) Takeda Chem. Indus. v. Mylan Labs., 2008 U.S. App. LEXIS (Fed. Cir. Dec. 8, 2008) Welker Bearing Co. v. PHD, Inc., 2008 U.S. App. LEXIS (Fed. Cir. Dec. 15, 2008) THANK YOU! Dallas Office 300 Crescent Court, Suite 1500 Dallas, TX Austin Office 300 West 6 th Street, Suite 1700 Austin, TX Marshall Office 104 E. Houston, Suite 300 Marshall, TX Washington Office 1700 K Street, N.W. Suite 740 Washington, DC New York Office 399 Park Avenue, Suite 3200 New York, NY
Life Sciences Industry Perspective on Declaratory Judgment Actions and Licensing Post-MedImmune. Roadmap for Presentation
Life Sciences Industry Perspective on Declaratory Judgment Actions and Licensing Post-MedImmune MedImmune: R. Brian McCaslin, Esq. Christopher Verni, Esq. March 9, 2009 clients but may be representative
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit TEVA PHARMACEUTICALS USA, INC., THROUGH ITS GATE PHARMACEUTICALS DIVISION, Plaintiff-Appellant, v. EISAI CO., LTD. AND EISAI MEDICAL RESEARCH, INC.,
More informationSome Declaratory Judgment Guidance For ANDA Litigants
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Some Declaratory Judgment Guidance For ANDA Litigants
More informationNo IN THE EISAI CO. LTD AND EISAI MEDICAL RESEARCH, INC., TEVA PHARMACEUTICALS USA, INC., through its GATE PHARMACEUTICALS Division,
No. 10-1070 ~[~ 2 7 7.i~[ IN THE EISAI CO. LTD AND EISAI MEDICAL RESEARCH, INC., Petitioners, TEVA PHARMACEUTICALS USA, INC., through its GATE PHARMACEUTICALS Division, Respondent. ON PETITION FOR A WRIT
More informationUnited States Court of Appeals for the Federal Circuit
Case: 14-1282 Case: CASE 14-1282 PARTICIPANTS Document: ONLY 44 Document: Page: 1 43 Filed: Page: 05/30/2014 1 Filed: 05/30/2014 2014-1282, -1291 United States Court of Appeals for the Federal Circuit
More informationCase 1:11-cv PAC Document 25 Filed 10/14/11 Page 1 of 11
Case 1:11-cv-02541-PAC Document 25 Filed 10/14/11 Page 1 of 11 USDC SDNY DOCUMENT UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ------------------------------------------------------------------X
More informationTeva v. EISAI: What's the Real Controversy
Michigan Telecommunications and Technology Law Review Volume 18 Issue 1 2011 Teva v. EISAI: What's the Real Controversy Grace Wang University of Michigan Law School Follow this and additional works at:
More informationThe Changing Landscape of Declaratory Judgment Jurisdiction: MedImmune v. Genentech and its Federal Circuit Progeny
The Changing Landscape of Declaratory Judgment Jurisdiction: MedImmune v. Genentech and its Federal Circuit Progeny Where are we now? Jan. 9, 2007 Supreme Court decides MedImmune v. Genentech March 26,
More information2010 Thomson Reuters. No Claim to Orig. US Gov. Works.
Page 1 United States Court of Appeals, Federal Circuit. CARACO PHARMACEUTICAL LABORATO- RIES, LTD., Plaintiff-Appellant, v. FOREST LABORATORIES, INC., Forest Laboratories Holdings, Ltd., and H. Lundbeck
More informationNo FOREST LABORATORIES, INC., FORES~LASO~TO~S Hot~mes, L~., ~D H. LU~.CK A/S, Petitioners,
No. 08-624 FOREST LABORATORIES, INC., FORES~LASO~TO~S Hot~mes, L~., ~D H. LU~.CK A/S, Petitioners, CARACO PHARI~CEUTICAL LABORATORIES, L~D., Respondent. On Petition for Writ of Certiorari To the United
More informationFish & Richardson Declaratory Judgment Post-Medimmune Presentation
Fish & Richardson Declaratory Judgment Post-Medimmune Presentation Where are we now? Jan. 9, 2007 Supreme Court decides MedImmune v. Genentech March 26, 2007 Federal Circuit decides SanDisk v. STMicroelectronics
More informationCase 3:06-cv JSW Document 203 Filed 02/12/2008 Page 1 of 6
Case :0-cv-00-JSW Document 0 Filed 0//00 Page of 0 0 R. Scott Jerger (pro hac vice (Oregon State Bar #0 Field Jerger LLP 0 SW Alder Street, Suite 0 Portland, OR 0 Tel: (0 - Fax: (0-0 Email: scott@fieldjerger.com
More informationSupreme Court of the United States
NO. 15-307 In the Supreme Court of the United States MYLAN PHARMACEUTICALS INC., v. Petitioner, APOTEX INC., Respondent. On Petition for Writ of Certiorari to the U.S. Court of Appeals for the Federal
More informationDeclaratory Judgment Actions in Patent Cases: The Federal Circuit's Response to MedImmune v. Genetech
Berkeley Technology Law Journal Volume 23 Issue 1 Article 8 January 2008 Declaratory Judgment Actions in Patent Cases: The Federal Circuit's Response to MedImmune v. Genetech Jennifer R. Saionz Follow
More informationSUCCESSFULLY LITIGATING METHOD OF USE PATENTS IN THE U.S.
SUCCESSFULLY LITIGATING METHOD OF USE PATENTS IN THE U.S. The 10 th Annual Generics, Supergenerics, and Patent Strategies Conference London, England May 16, 2007 Provided by: Charles R. Wolfe, Jr. H. Keeto
More informationUnited States District Court, Northern District of Illinois
Order Form (01/2005) United States District Court, Northern District of Illinois Name of Assigned Judge or Magistrate Judge Blanche M. Manning Sitting Judge if Other than Assigned Judge CASE NUMBER 06
More informationUnited States Court of Appeals for the Federal Circuit
Case: 14-1282 Document: 62 Page: 1 Filed: 09/29/2014 2014-1282, -1291 United States Court of Appeals for the Federal Circuit APOTEX INC., Plaintiff-Appellant, v. DAIICHI SANKYO, INC., AND DAIICHI SANKYO
More informationInfringement Assertions In The New World Order
Infringement Assertions In The New World Order IP Law360, October 17, 2007, Guest Column Author(s): Charles R. Macedo, Michael J. Kasdan Wednesday, Oct 17, 2007 The recent Supreme Court and Federal Circuit
More informationProveris Scientific Corp. v. Innovasystems, Inc.
Berkeley Technology Law Journal Volume 24 Issue 1 Article 10 January 2009 Proveris Scientific Corp. v. Innovasystems, Inc. Berkeley Technology Law Journal Follow this and additional works at: http://scholarship.law.berkeley.edu/btlj
More informationPOST-MEDIMMUNE DEVELOPMENTS REGARDING DECLARATORY JUDGMENT JURISDICTION
POST-MEDIMMUNE DEVELOPMENTS REGARDING DECLARATORY JUDGMENT JURISDICTION The Federal Circuit's Recent SanDisk and Teva Pharmaceuticals Decisions On March 26 and 30, the U.S. Court of Appeals for the Federal
More informationCase 3:14-cv MLC-TJB Document Filed 07/24/15 Page 2 of 16 PageID: 1111 TABLE OF CONTENTS INTRODUCTION... 1 BACKGROUND...
Case 3:14-cv-02550-MLC-TJB Document 100-1 Filed 07/24/15 Page 1 of 16 PageID: 1110 Keith J. Miller Michael J. Gesualdo ROBINSON MILLER LLC One Newark Center, 19th Floor Newark, New Jersey 07102 Telephone:
More informationUNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
Case: 16-2641 Document: 45-1 Page: 1 Filed: 09/13/2017 (1 of 11) UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT NOTICE OF ENTRY OF JUDGMENT ACCOMPANIED BY OPINION OPINION FILED AND JUDGMENT ENTERED:
More informationIN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION
IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION JACK HENRY & ASSOCIATES INC., et al., Plaintiffs, v. Civil Action No. 3:15-CV-3745-N PLANO ENCRYPTION TECHNOLOGIES, LLC, Defendant.
More informationORDER GRANTING IN PART AND DENYING IN PART MOTION TO TRANSFER OR STAY
Pfizer Inc. et al v. Sandoz Inc. Doc. 50 Civil Action No. 09-cv-02392-CMA-MJW IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Judge Christine M. Arguello PFIZER, INC., PFIZER PHARMACEUTICALS,
More informationUNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY WARNER CHILCOTT COMPANY, LLC, et al., Plaintiffs, Civil Action No. 11-6936 (SRC) v. OPINION & ORDER TEVA PHARMACEUTICALS USA, INC., Defendant. CHESLER,
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE POSITEC USA INC., and POSITEC USA INC., Plaintiffs, C.A. No. 05-890 GMS v. MILWAUKEE ELECTRIC TOOL CORPORATION, Defendant. MEMORANDUM I.
More informationCase: 1:16-cv Document #: 1 Filed: 03/09/16 Page 1 of 13 PageID #:1 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION
Case: 1:16-cv-02988 Document #: 1 Filed: 03/09/16 Page 1 of 13 PageID #:1 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION TORRENT PHARMACEUTICALS LIMITED, and TORRENT PHARMA
More informationThe Roadblock for Generic Drugs: Declaratory Judgment Jurisdiction for Later Generic Challengers
NORTH CAROLINA JOURNAL OF LAW & TECHNOLOGY Volume 15 Issue 1 Article 3 10-1-2013 The Roadblock for Generic Drugs: Declaratory Judgment Jurisdiction for Later Generic Challengers Matthew Avery Mary Nguyen
More informationLicense Agreements and Litigation: Protecting Your Assets and Revenue Streams in the High-Tech and Life Science Industries
License Agreements and Litigation: Protecting Your Assets and Revenue Streams in the High-Tech and Life Science Industries January 21, 2010 *These materials represent our preliminary analysis based on
More informationFrom PLI s Program New Strategies Arising from the Hatch-Waxman Amendments #4888
From PLI s Program New Strategies Arising from the Hatch-Waxman Amendments #4888 New Strategies Arising From the Hatch-Waxman Amendments Practicing Law Institute Telephone Briefing May 12, 2004 I. INTRODUCTION
More informationA Nonrepudiating Patent Licensee s Right To Seek Declaratory Judgment of Invalidity or Noninfringement of the Licensed Patent: MedImmune v.
Order Code RL34156 A Nonrepudiating Patent Licensee s Right To Seek Declaratory Judgment of Invalidity or Noninfringement of the Licensed Patent: MedImmune v. Genentech August 30, 2007 Brian T. Yeh Legislative
More informationPENDING LEGISLATION REGULATING PATENT INFRINGEMENT SETTLEMENTS
PENDING LEGISLATION REGULATING PATENT INFRINGEMENT SETTLEMENTS By Edward W. Correia* A number of bills have been introduced in the United States Congress this year that are intended to eliminate perceived
More informationJONES DAY 222 East 41 st Street New York, NY Tel: (212) Fax: (212)
UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK ASSOCIATION FOR MOLECULAR PATHOLOGY; AMERICAN COLLEGE OF MEDICAL GENETICS; AMERICAN SOCIETY FOR CLINICAL PATHOLOGY; COLLEGE OF AMERICAN
More informationPay-for-Delay Settlements: Antitrust Violation or Proper Exercise of Pharmaceutical Patent Rights?
Pay-for-Delay Settlements: Antitrust Violation or Proper Exercise of Pharmaceutical Patent Rights? By Kendyl Hanks, Sarah Jacobson, Kyle Musgrove, and Michael Shen In recent years, there has been a surge
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH CENTRAL DIVISION
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH CENTRAL DIVISION VOILÉ MANUFACTURING CORP., Plaintiff, ORDER and MEMORANDUM DECISION vs. LOUIS DANDURAND and BURNT MOUNTAIN DESIGNS, LLC, Case
More informationPutting the Law (Back) in Patent Law
Putting the Law (Back) in Patent Law Some Thoughts on the Supreme Court s MedImmune Decision 21 March 2007 Joe Miller - Lewis & Clark Law School 1 Back in the Patent Game October 2005 Term Heard three
More informationAn ANDA Update. June 2004 Bulletin 04-50
June 2004 Bulletin 04-50 If you have questions or would like additional information on the material covered in this Bulletin, please contact one of the authors: Mark R. Shanks 202.414.9201 mshanks@reedsmith.com
More informationCase 3:11-cv JAP -TJB Document 32 Filed 07/06/11 Page 1 of 19 PageID: 530 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY
Case 3:11-cv-03111-JAP -TJB Document 32 Filed 07/06/11 Page 1 of 19 PageID: 530 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY : NOSTRUM PHARMACEUTICALS, LLC, : : Plaintiff,
More informationUNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
PHARMANET, INC. et al v. DATASCI LIMITED LIABILITY COMPANY Doc. 14 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY : PHARMANET, INC. et. al., : : Civ. No. 08-2965 (GEB) Plaintiffs,
More informationCase 1:12-cv SLR Document 18 Filed 08/27/12 Page 1 of 17 PageID #: 71 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:12-cv-00809-SLR Document 18 Filed 08/27/12 Page 1 of 17 PageID #: 71 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE PFIZER INC., WYETH LLC, WYETH PHARMACEUTICALS INC., and PF PRISM
More informationRECENT DEVELOPMENTS IN PATENT LAW
RECENT DEVELOPMENTS IN PATENT LAW Kristen Jakobsen Osenga * I. Introduction... 304 II. Patentability Requirements... 304 A. 102:... 305 B. 103:... 306 C. 112:... 308 III. Patent Prosecution Issues... 310
More informationRECENT FEDERAL CIRCUIT DECISIONS ASSESSING JURISDICTION Richard Basile Partner St. Onge Steward Johnston & Reens LLC Stamford CT
RECENT FEDERAL CIRCUIT DECISIONS ASSESSING JURISDICTION Richard Basile Partner St. Onge Steward Johnston & Reens LLC Stamford CT I. INTRODUCTION During the last year the Court of Appeals for the Federal
More informationCase 1:09-cv JJF Document 36 Filed 02/09/10 Page 1 of 22 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:09-cv-00651-JJF Document 36 Filed 02/09/10 Page 1 of 22 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE BRISTOL-MYERS SQUIBB CO., and BRISTOL-MYERS SQUIBB PHARMA CO. Plaintiffs,
More informationCase5:12-cv RMW Document41 Filed10/10/12 Page1 of 10
Case:-cv-0-RMW Document Filed0/0/ Page of 0 E-FILED on 0/0/ 0 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION REALTEK SEMICONDUCTOR CORPORATION, v. Plaintiff,
More informationCaraco V. Novo Nordisk: Antitrust Implications
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Caraco V. Novo Nordisk: Antitrust Implications Law360,
More informationWIPO Conference on IP Dispute Resolution in Life Sciences 2016 Amanda K. Murphy, Ph.D.
Finnegan Europe LLP WIPO Conference on IP Dispute Resolution in Life Sciences 2016 Amanda K. Murphy, Ph.D. 1 U.S. Judicial System U.S. Supreme Court Quasi- Judicial Federal Agencies Federal Circuit International
More informationCase 1:14-cv IMK Document 125 Filed 06/16/14 Page 1 of 21 PageID #: 1959
Case 1:14-cv-00075-IMK Document 125 Filed 06/16/14 Page 1 of 21 PageID #: 1959 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF WEST VIRGINIA MYLAN PHARMACEUTICALS, INC., Plaintiff, WATSON
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit 2007-1553 AVOCENT HUNTSVILLE CORP. and AVOCENT REDMOND CORP., v. Plaintiffs-Appellants, ATEN INTERNATIONAL CO., LTD., Defendant-Appellee. James D.
More informationPharmaceutical Pay for Delay Settlements
Pharmaceutical Pay for Delay Settlements UCIP Seminar 12 November 2012 www.morganlewis.com Outline Background Goals of the Hatch-Waxman Act Price Effects of Generic Entry Pay-for-Delay Patent Settlements
More informationUnited States Court of Appeals for the Federal Circuit
Case: 18-131 Document: 38 Page: 1 Filed: 06/13/2018 NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit In re: INTEX RECREATION CORP., INTEX TRADING LTD., THE COLEMAN
More informationWe Innovate Healthcare 1
Kimberly J. Prior Hoffmann-La Roche Inc. December 5, 2012 We Innovate Healthcare 1 The doctrine of obviousness-type double patenting is intended to prevent the extension of the term of a patent by prohibiting
More informationPharmaceutical Formulations: Ready For Patenting?
Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Pharmaceutical Formulations: Ready For Patenting?
More informationappropriate measure of damages to which plaintiff Janssen Biotech,
UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS JANSSEN BIOTECH, INC. ET AL, Plaintiffs, V. C.A. No. 15-10698-MLW 16-11117-MLW CELLTRION HEALTHCARE CO. INC., ET AL., Defendants. MEMORANDUM AND ORDER
More informationTHE DISTRICT COURT CASE
Supreme Court Sets the Bar High, Requiring Knowledge or Willful Blindness to Establish Induced Infringement of a Patent, But How Will District Courts Follow? Peter J. Stern & Kathleen Vermazen Radez On
More informationInter Partes Review vs. District Court Litigation
Inter Partes Review vs. District Court Litigation February 19, 2015 2 PM ET Ha Kung Wong Inter Partes Review vs. District Court Litigation February 19, 2015 2 PM ET Ha Kung Wong Debbie Gibson v. Tiffany
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE MEMORANDUM ORDER
3G LICENSING, S.A., KONINKLIJKE KPN N.V. and ORANGES.A., Plaintiffs, IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE v. Civil Action No. 17-83-LPS-CJB HTC CORPORATION and HTC - AMERICA
More informationUNITED STATES DISTRICT COURT EASTERN DISTRICT OF WISCONSIN. v. Case No. 14-CV Counterclaim-Plaintiffs, Counterclaim-Defendants.
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF WISCONSIN KIMBERLY-CLARK WORLDWIDE INC. et al., Plaintiffs, v. Case No. 14-CV-1466 FIRST QUALITY BABY PRODUCTS LLC et al., Defendants. FIRST QUALITY BABY
More informationthe "Approved Drug Products with Therapeutic Equivalence Evaluations," commonly
Case 3:14-cv-00422-HEH Document 29 Filed 10/14/14 Page 1 of 13 PageID# 202 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA Richmond Division GLENMARK GENERICS LTD., et. al, v.
More informationBusiness Method Patents on the Chopping Block?
Business Method Patents on the Chopping Block? ACCA, San Diego Chapter General Counsel Roundtable and All Day MCLE Eric Acker and Greg Reilly Morrison & Foerster LLP San Diego, CA 2007 Morrison & Foerster
More informationHealth Care Law Monthly
Health Care Law Monthly February 2013 Volume 2013 * Issue No. 2 Contents: Copyright ß 2013 Matthew Bender & Company, Inc., a member of the Lexis- Nexis group of companies. All rights reserved. HEALTH CARE
More informationFDA, PATENT TERM EXTENSIONS AND THE HATCH WAXMAN ACT. Dr.Sumesh Reddy- Dr. Reddys Lab Hyderabad-
FDA, PATENT TERM EXTENSIONS AND THE HATCH WAXMAN ACT Dr.Sumesh Reddy- Dr. Reddys Lab Hyderabad- FDA Regulatory approval-time and cost Focus of FDA approval process-safety and efficacy Difference between
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE MALLINCKRODT IP, MALLINCKRODT HOSPITAL PRODUCTS INC., and SCR PHARMATOP, v. Plaintiffs, C.A. No. 17-365-LPS B. BRAUN MEDICAL INC.,. Defendant.
More informationORDER. Background IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS AUSTIN DIVISION. Case No. A-14-CA-1007-SS
IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS AUSTIN DIVISION 2C15 MAR 26 PM 3: 08 CATALYST MEDIUM FOUR, INC., Plaintiff, -vs- Case No. A-14-CA-1007-SS CARDSHARK, LLC, Defendant.
More informationIN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF TEXAS HOUSTON DIVISION. v. CIVIL ACTION NO. H Defendants.
IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF TEXAS HOUSTON DIVISION United States District Court Southern District of Texas ENTERED October 09, 2018 David J. Bradley, Clerk NEURO CARDIAC
More informationJurisdiction In Hatch-Waxman Actions Against Foreign Entities
Jurisdiction In Hatch-Waxman Actions Against Foreign Entities Law360, New York (October 19, 2015, 10:36 AM ET) - The 2014 U.S. Supreme Court decision in Daimler AG v. Bauman[1] has increased challenges
More informationSupreme Court of the United States
NO. In the Supreme Court of the United States MYLAN PHARMACEUTICALS INC., v. Petitioner, APOTEX INC., Respondent. On Petition for Writ of Certiorari to the U.S. Court of Appeals for the Federal Circuit
More informationRAMBUS, INC. v. FEDERAL TRADE COMMISSION Impact on Standards and Antitrust
RAMBUS, INC. v. FEDERAL TRADE COMMISSION Impact on Standards and Antitrust American Intellectual Property Law Association IP Practice in Japan Committee October 2009, Washington, DC JOHN A. O BRIEN LAW
More informationWill Nationwide Venue for Patent Infringement Suits Soon End? David Kitchen Shannon McCue
Will Nationwide Venue for Patent Infringement Suits Soon End? David Kitchen Shannon McCue Syllabus Brief review of patent jurisdiction and venue. Historical review of patent venue decisions, focusing on
More informationIN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION. Plaintiff, Civil Action No. 3:09-CV-1978-L v.
Expedite It AOG, LLC v. Clay Smith Engineering, Inc. Doc. 20 IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION EXPEDITE IT AOG, LLC D/B/A SHIP IT AOG, LLC, Plaintiff, Civil
More informationUNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA
1 1 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA PRESIDIO COMPONENTS, INC., Plaintiff, vs. AMERICAN TECHNICAL CERAMICS CORP., Defendant. CASE NO. -CV-1-H (BGS) ORDER: (1) GRANTING IN PART
More informationIN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA ) ) ) ) ) ) ) ) ) ) MEMORANDUM OPINION
CARNEGIE MELLON UNIVERSITY v. MARVELL TECHNOLOGY GROUP, LTD. et al Doc. 447 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA CARNEGIE MELLON UNIVERSITY, v. Plaintiff, MARVELL
More informationNo. lo- IN TH~ EISAI CO. LTD. AND EISAI MEDICAL RESEARCH, INC., Petitioners,
No. lo- IN TH~ EISAI CO. LTD. AND EISAI MEDICAL RESEARCH, INC., Petitioners, TEVA PHARMACEUTICALS USA, INC., through its GATE PHARMACEUTICALS Division, Respondent. On Petition for a Writ of Certiorari
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit JACK HENRY & ASSOCIATES, INC., COMMUNITY BANK OF TEXAS NA, AMERICAN NATIONAL BANK OF TEXAS NA, GREEN BANCORP, INC., GREEN BANK NA, MOODY NATIONAL
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit IN RE BARNES & NOBLE, INC., Petitioner. Miscellaneous Docket No. 162 On Petition for Writ of Mandamus to the United States District Court for the
More informationCase 3:17-cv M Document 144 Filed 05/30/18 Page 1 of 8 PageID 3830
Case 3:17-cv-01495-M Document 144 Filed 05/30/18 Page 1 of 8 PageID 3830 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION SEVEN NETWORKS, LLC, Plaintiff, v. ZTE (USA),
More informationUnited States Court of Appeals for the Federal Circuit
NOTE: Pursuant to Fed. Cir. R. 47.6, this disposition is not citable as precedent. It is a public record. United States Court of Appeals for the Federal Circuit 05-1390 JOHN FORCILLO, Plaintiff-Appellee,
More informationUNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA
Case :0-cv-0-H-KSC Document Filed // Page of 0 0 MULTIMEDIA PATENT TRUST, vs. APPLE INC., et al., UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA Plaintiff, Defendants. CASE NO. 0-CV--H (KSC)
More informationCase 3:15-cv MAS-LHG Document 1 Filed 04/06/15 Page 1 of 38 PageID: 1
Case 3:15-cv-02520-MAS-LHG Document 1 Filed 04/06/15 Page 1 of 38 PageID: 1 Liza M. Walsh, Esq. CONNELL FOLEY LLP 85 Livingston Avenue Roseland, New Jersey 07068-1765 (973) 535-0500 Of Counsel: William
More informationIN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK
Case 1:11-cv-02037-UA Document 13 Filed 06/01/11 Page 1 of 12 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK ) PURDUE PHARMA L.P., ) THE P.F. LABORATORIES, INC., ) PURDUE PHARMACEUTICALS
More informationBrief Summary of Precedential Patent Case Law For the Period to
Brief Summary of Precedential Patent Case Law For the Period 11-9-2017 to 12-13-2017 By Rick Neifeld, Neifeld IP Law, PC This article presents a brief summary of relevant precedential points of law during
More informationCase 1:07-cv RMU Document 71-2 Filed 05/08/2007 Page 1 of 6. ANDA , Amlodipine Besylate Tablets, 2.5 mg, 5 mg, and 10 mg.
Case 1:07-cv-00579-RMU Document 71-2 Filed 05/08/2007 Page 1 of 6 DEPARTMENT OF HEALTH & HUMAN SERVICES ANDA 76-719, Amlodipine Besylate Tablets, 2.5 mg, 5 mg, and 10 mg. SENT BY FACSIMILE AND U.S. MAIL
More informationThe Changing Landscape of AIA Proceedings
The Changing Landscape of AIA Proceedings Presented by: Gina Cornelio, Partner, Patent Clint Conner, Partner, Intellectual Property Litigation June 20, 2018 The Changing Landscape of AIA Proceedings Gina
More informationCase 3:16-cv MAS-LHG Document 1 Filed 09/16/16 Page 1 of 14 PageID: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY
Case 3:16-cv-05678-MAS-LHG Document 1 Filed 09/16/16 Page 1 of 14 PageID: 1 Liza M. Walsh Tricia B. O Reilly Katelyn O Reilly WALSH PIZZI O REILLY FALANGA LLP 1037 Raymond Boulevard, Suite 600 Newark,
More informationAmerica Invents Act (AIA) The Patent Reform Law of 2011 Initial Summary
PRESENTATION TITLE America Invents Act (AIA) The Patent Reform Law of 2011 Initial Summary Christopher M. Durkee James L. Ewing, IV September 22, 2011 1 Major Aspects of Act Adoption of a first-to-file
More informationIntellectual Property Law
SMU Law Review Volume 62 2009 Intellectual Property Law David L. McCombs Phillip B. Philbin Donald E. Tiller Follow this and additional works at: https://scholar.smu.edu/smulr Recommended Citation David
More informationVENUE-RELATED ISSUES IN PATENT INFRINGEMENT & HATCH-WAXMAN LITIGATIONS
VENUE-RELATED ISSUES IN PATENT INFRINGEMENT & HATCH-WAXMAN LITIGATIONS IIPRD SEMINAR- NOV. 2018 MARK BOLAND SUGHRUE MION, PLLC 1 TC HEARTLAND SHIFTS PATENT VENUE LANDSCAPE BY LIMITING WHERE CORPORATIONS
More informationCase 1:16-cv UNA Document 1 Filed 04/07/16 Page 1 of 17 PageID #: 1 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ) ) ) ) ) ) ) ) )
Case 1:16-cv-00237-UNA Document 1 Filed 04/07/16 Page 1 of 17 PageID #: 1 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FRESENIUS KABI USA, LLC, Plaintiff, v. MAIA PHARMACEUTICALS, INC., Defendant.
More informationUNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS MARSHALL DIVISION
Case 2:07-cv-00474-TJW Document 146 Filed 06/18/2008 Page 1 of 16 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS MARSHALL DIVISION WI-LAN, INC., Plaintiff, Case No. 2:07-CV-474 v. Hon. T. John
More informationTC Heartland s Restraints On ANDA Litigation Jurisdiction
Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com TC Heartland s Restraints On ANDA Litigation
More informationPharmaceutical Patent Settlement Cases: Mixed Signals for Settling Patent Litigation
By Margaret J. Simpson Tel: 312 923-2857 Fax: 312 840-7257 E-mail: msimpson@jenner.com The following article originally appeared in the Spring 2004 issue of the Illinois State Bar Association s Antitrust
More informationCase 1:18-cv UNA Document 1 Filed 01/19/18 Page 1 of 14 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:18-cv-00117-UNA Document 1 Filed 01/19/18 Page 1 of 14 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE TEVA PHARMACEUTICALS INTERNATIONAL GMBH, CEPHALON, INC., and EAGLE
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit 2009-1071 ELI LILLY AND COMPANY, Plaintiff-Appellee, v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant. Charles E. Lipsey, Finnegan, Henderson,
More informationUnited States Court of Appeals for the Federal Circuit
Case: 17-107 Document: 16 Page: 1 Filed: 02/23/2017 NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit In re: GOOGLE INC., Petitioner 2017-107 On Petition for Writ
More informationThe Latest On Fee-Shifting In Patent Cases
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com The Latest On Fee-Shifting In Patent Cases Law360,
More informationIN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS MARSHALL DIVISION
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS MARSHALL DIVISION WHIRLPOOL CORPORATION, Plaintiff, v. AHMET MATT OZCAN d/b/a HESSLA, Defendant. Civil Action No. 2:15-cv-1656-JRG
More informationUNITED STATES COURT OF APPEALS
Case: 14-1294 Document: 71 Page: 1 Filed: 10/31/2014 NO. 2014-1294 IN THE UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT PURDUE PHARMA L.P., THE P.F. LABORATORIES, INC., PURDUE PHARMACEUTICALS
More informationTechnology Contracts and Agreements: A Practice Guide to Effective Negotiation, Drafting and Strategy
Technology Contracts and Agreements: A Practice Guide to Effective Negotiation, Drafting and Strategy Keith Witek Director of Strategy & Corp Development AMD Ed Cavazos Principal Fish & Richardson P.C.
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit 03-1541, 04-1137, -1213 EVIDENT CORPORATION, Plaintiff/Counterclaim Defendant- Appellant, and PEROXYDENT GROUP, v. CHURCH & DWIGHT CO., INC., Counterclaim
More informationPharmaceutical Product Improvements and Life Cycle Management Antitrust Pitfalls 1
Pharmaceutical Product Improvements and Life Cycle Management Antitrust Pitfalls 1 The terms product switching, product hopping and line extension are often used to describe the strategy of protecting
More informationPatent Enforcement Pre-Litigation Considerations
Patent Enforcement Pre-Litigation Considerations The Intellectual Property Society April 10, 2005 Patrick Reilly 1 I. Pre-Litigation Check-List 2 Purposes of a Pre-Litigation Check-List Validity Can the
More information